News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

StoneBridge Pharma, LLC And Capellon Pharmaceuticals Announce Co-Promotion Agreement To Market Symax™ Duotab (Hyoscyamine Sulfate) For Irritable Bowel Syndrome


10/12/2006 11:29:09 AM

DULUTH, Ga.--(BUSINESS WIRE)--StoneBridge Pharma, LLC of Duluth, Georgia and Capellon Pharmaceuticals of Fort Worth, Texas, have announced a co-promotion agreement to market Capellon’s adjunctive treatment for irritable bowel syndrome (IBS) -- Symax™ Duotab (hyoscyamine sulfate) biphasic tablet.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES